Bizmoon
Grants & Loans
Regulations
Industries
Sign in
Learn more
Bizmoon

Product

  • Grants
  • Regulations
  • How it works
  • Pricing
  • Blog

Industries

  • Healthcare
  • Trade and Commerce
  • Transportation and Logistics
  • Energy and Utilities
  • Finance and Banking
  • Land and Natural Resources
  • Agriculture

Coverage

  • All grants
  • All regulations
  • Federal grants
  • Federal regulations

Company

  • Careers
  • Sign in
© 2026 BizmoonPrivacyTermsCredits
  1. Home
  2. Regulations
  3. Federal
  4. Page 2

Federal regulations

Agency
  • DOC231
  • DOT212
  • SEC
201
  • HHS185
  • FDA159
  • DOE146
  • DHS142
  • FERC130
  • FAA96
  • EPA83
  • NOAA76
  • NIH53
  • DOJ51
  • Treasury50
  • USDA47
  • DOL38
  • FCC25
  • SBA23
  • CMS18
  • IRS18
  • HUD17
  • FTC5
  • Topic
    • Compliance3
    • Operations2
    • Administration1
    • Finance1
    • Human Resources1
    Recency
    • Last 30 days
    • Last 7 days
    CMSRemove filter: CMSDOJRemove filter: DOJFDARemove filter: FDAClear all
    • Medical Devices; Gastroenterology-Urology Devices; Classification of the Ingestible Gastrointestinal Blood Detection Capsule
      June 17, 2026

      FDA classifies ingestible gastrointestinal blood detection capsules as class II devices, establishing special controls to ensure safety and effectiveness while reducing regulatory burden for manufacturers.

    • Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
      June 17, 2026

      AndersonBrecon, Inc. DBA PCI Pharma Services has applied for DEA registration as an importer of controlled substances; details on specific drug classes are available in supplementary information.

    • Masuu Global Solutions LLC, U.S. Agent for Extrovis AG, et al.; Withdrawal of Approval of 11 Abbreviated New Drug Applications; Correction
      June 16, 2026

      FDA corrects withdrawal of approval for 11 abbreviated new drug applications; Masuu Global Solutions LLC's propranolol and lidocaine ANDAs remain approved as of March 23, 2026.

    • Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
      June 16, 2026

      Proposed rule codifies Medicare Drug Price Negotiation Program under the Inflation Reduction Act of 2022 and establishes new policies for drug benefit programs and fixed combination drugs.

    • Agency Information Collection Activities: Submission for OMB Review; Comment Request
      June 16, 2026

      CMS is soliciting public comments on proposed information collection activities under the Paperwork Reduction Act; interested parties may submit feedback on burden estimates and collection methodology.

    • Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflicts of Interest, and Related Provisions
      June 16, 2026

      Medicare's final rule strengthens oversight of accrediting organizations by addressing conflicts of interest, establishing consistent standards, and updating validation systems for deemed providers and suppliers across multiple care settings.

    • Agency Information Collection Activities; Proposed eCollection eComments Requested; New collection; Requests for DOJ Certification Letters for T Visa Holders
      June 16, 2026

      DOJ's Office of Justice Programs seeks OMB approval for a new information collection on T visa certification letter requests; public comments accepted through the Federal Register notice period.

    • Western Mixers Produce & Nuts Issues Allergy Alert on Undeclared Peanuts in First Street Brand, Dark Chocolate Raisins
      June 15, 2026

      Western Mixers Produce & Nuts recalls 9 oz. First Street brand Dark Chocolate Raisins due to undeclared peanuts posing serious risk to allergic consumers.

    • Importer of Controlled Substances Application: Cerilliant Corporation
      June 15, 2026

      Cerilliant Corporation seeks DEA registration as an importer of controlled substances; refer to supplementary information for specific drug classes.

    • Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.
      June 15, 2026

      Veranova, L.P. has applied for DEA registration as a bulk manufacturer of controlled substances; supplementary drug information is available in regulatory notices.

    PreviousPage 2 of 23 (228 total)Next

    Track Federal regulations for your business

    Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.

    Action items + deadlines

    Every rule is broken into specific to-dos with calendar dates.

    Affected areas

    We tell you which parts of your business each rule actually touches.

    Plain-English summaries

    Healthcare draws more federal rulemaking than any other sector

    After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.

    Federal rulemaking

    • Healthcare and life sciences
    • Trade and commerce
    • Transportation and aviation
    • Energy and utilities
    • Finance
    • Natural resources
    • Other

    Browse by agency

    • CMS
    • DHS
    • DOC
    • DOE
    • DOJ
    • DOL

    Browse by state

    • Alabama
    • Arizona
    • California
    • Colorado
    • Florida
    • Illinois

    No legal jargon. Read the impact in two sentences.

    Real-time alerts

    Email + dashboard pings the moment something changes.

    Get started free
  • DOT
  • EPA
  • FAA
  • FCC
  • FDA
  • FERC
  • FTC
  • HHS
  • HUD
  • IRS
  • NIH
  • NOAA
  • SBA
  • SEC
  • Treasury
  • USDA
  • Kentucky
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Missouri
  • New York
  • North Carolina
  • Ohio
  • Pennsylvania
  • South Carolina
  • Tennessee
  • Texas
  • Virginia
  • Washington
  • Wisconsin
  • Federal grants